No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
ANI Gets FDA Approval for Generic Motegrity
Takeda-backed Ascentage Pharma Files for $100M IPO
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Takeda Gains Approval For HYQVIA In Japan To Treat Immunodeficiency
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases